RxDoctor Payments Data

Yia Lor, NP

Family · Little Chute, WINPI 1629683065

Payments from drug & device makers

$1,000in general payments, 2019–2025

Across 67 payments — averaging $14.93 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$678
  • Collegium Pharmaceutical, Inc.$95
  • IBSA Pharma Inc.$70
  • Tersera Therapeutics LLC$45
  • Pfizer$32
  • Biodelivery Sciences International, Inc.$30
  • plus $50 from 3 others

What the payments were for

  • Food & beverage$1,000100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,000 in reported general payments places this provider in the 80th percentile of 1,273 family providers in Wisconsin.

See all family providers in Wisconsin

Medicare billing

Part B allowed, 2024
$45,188
Medicare patients
86
Services billed
588

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
BelbucaBuprenorphine Hcl106$92,377
Buprenorphine76$26,200
Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl178$21,730
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen864$21,551
Morphine Sulfate ErMorphine Sulfate297$6,805
OxycontinOxycodone Hcl17$6,698
NucyntaTapentadol Hcl15$6,303
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen185$6,232
Buprenorphine Hcl153$3,979
Gabapentin214$2,687
Pregabalin122$2,510
Morphine Sulfate67$2,104
Naloxone Hcl29$1,952
Colchicine55$1,719
Tizanidine Hcl136$1,589

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Collegium Pharmaceutical, Inc.Belbuca, Nucynta$95$98,680121 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 1,273 family providers in Wisconsin.

Other family in Little Chute

See the full list for Wisconsin

Where these figures come from

Is this you, or does something look wrong? →